BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21371883)

  • 1. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.
    Yu H; Su J; Xu Y; Kang J; Li H; Zhang L; Yi H; Xiang X; Liu F; Sun L
    Eur J Cancer; 2011 Jul; 47(10):1585-94. PubMed ID: 21371883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system.
    Xia M; Yu H; Gu S; Xu Y; Su J; Li H; Kang J; Cui M
    Int J Oncol; 2014 Dec; 45(6):2341-8. PubMed ID: 25269472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.
    Shen C; Wang W; Tao L; Liu B; Yang Z; Tao H
    Int J Mol Med; 2013 Aug; 32(2):448-56. PubMed ID: 23722646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
    Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
    Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin.
    Zhu J; Lin S; Zou X; Chen X; Liu Y; Yang X; Gao J; Zhu H
    Mol Biol Rep; 2023 Aug; 50(8):6457-6468. PubMed ID: 37326754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
    Yan XY; Zhang Y; Zhang JJ; Zhang LC; Liu YN; Wu Y; Xue YN; Lu SY; Su J; Sun LK
    Cancer Sci; 2017 Jul; 108(7):1405-1413. PubMed ID: 28498503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma].
    Tian J; Hu X; Qu Q
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function.
    Ma L; Xu Y; Su J; Yu H; Kang J; Li H; Li X; Xie Q; Yu C; Sun L; Li Y
    Int J Oncol; 2015 Nov; 47(5):1890-900. PubMed ID: 26397057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IL-17A/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy].
    Wang L; Zhang X; Wang L; Wang B; Zhang J; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1550-1556. PubMed ID: 33243748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
    Alsamman K; El-Masry OS
    Oncol Rep; 2018 Oct; 40(4):2157-2162. PubMed ID: 30106434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.
    Myeku N; Figueiredo-Pereira ME
    J Biol Chem; 2011 Jun; 286(25):22426-40. PubMed ID: 21536669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BH3 mimetic S1 induces endoplasmic reticulum stress-associated apoptosis in cisplatin-resistant human ovarian cancer cells although it activates autophagy.
    Liu N; Xu Y; Sun JT; Su J; Xiang XY; Yi HW; Zhang ZC; Sun LK
    Oncol Rep; 2013 Dec; 30(6):2677-84. PubMed ID: 24100381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins.
    Matsumoto G; Wada K; Okuno M; Kurosawa M; Nukina N
    Mol Cell; 2011 Oct; 44(2):279-89. PubMed ID: 22017874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells.
    Nguyen EV; Huhtinen K; Goo YA; Kaipio K; Andersson N; Rantanen V; Hynninen J; Lahesmaa R; Carpen O; Goodlett DR
    Mol Cell Proteomics; 2017 Jul; 16(7):1377-1392. PubMed ID: 28455291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
    Puissant A; Robert G; Fenouille N; Luciano F; Cassuto JP; Raynaud S; Auberger P
    Cancer Res; 2010 Feb; 70(3):1042-52. PubMed ID: 20103647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.
    Riz I; Hawley TS; Hawley RG
    Oncotarget; 2015 Jun; 6(17):14814-31. PubMed ID: 26109433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer.
    Yan XY; Zhong XR; Yu SH; Zhang LC; Liu YN; Zhang Y; Sun LK; Su J
    J Cell Mol Med; 2019 Jun; 23(6):4030-4042. PubMed ID: 30941888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.